| Literature DB >> 26973291 |
Prasad G Kamble1, Maria J Pereira1, Cherno O Sidibeh1, Sam Amini1, Magnus Sundbom2, Joey Lau Börjesson1, Jan W Eriksson3.
Abstract
The adipokine lipocalin 2 is linked to obesity and metabolic disorders. However, its role in human adipose tissue glucose and lipid metabolism is not explored. Here we show that the synthetic glucocorticoid dexamethasone dose-dependently increased lipocalin 2 gene expression in subcutaneous and omental adipose tissue from pre-menopausal females, while it had no effect in post-menopausal females or in males. Subcutaneous adipose tissue from both genders treated with recombinant human lipocalin 2 showed a reduction in protein levels of GLUT1 and GLUT4 and in glucose uptake in isolated adipocytes. In subcutaneous adipose tissue, lipocalin 2 increased IL-6 gene expression whereas expression of PPARγ and adiponectin was reduced. Our findings suggest that lipocalin 2 can contribute to insulin resistance in human adipose tissue. In pre-menopausal females, it may partly mediate adverse metabolic effects exerted by glucocorticoid excess.Entities:
Keywords: Glucocorticoids; Human adipose tissue; Insulin resistance; Lipocalin 2; PPARγ; Type 2 diabetes
Mesh:
Substances:
Year: 2016 PMID: 26973291 DOI: 10.1016/j.mce.2016.03.011
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102